Droxia
Company: Bristol-Myers Squibb
Approval Status: Approved March 1998
Treatment for: sickle-cell anemia
Areas: Hematology
General Information
Other Useful Resources
Droxia has been approved for people who have had three or more painful episodes with sickle-cell, which causes red blood cells to become oddly shaped and clump together. While taking the drug, patients must have a blood test every two weeks to ensure that their blood count is not depressed to a level at which they might be at risk for infection or bleeding.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
